Kabi

Monsha'at leads delegation of Saudi startups at Web Summit 2023

Retrieved on: 
Thursday, November 16, 2023
Kabi, SME, Web Summit, The Complete Master Works, Ecosystem, Small, Growth, MENA, Environment, Al-Nuqtah Mosque, Kingdom

Held from 13 to 16 November 2023 — in Lisbon, Portugal — the event provided Monsha'at the opportunity to spotlight Saudi Arabia's most innovative SMEs.

Key Points: 
  • Held from 13 to 16 November 2023 — in Lisbon, Portugal — the event provided Monsha'at the opportunity to spotlight Saudi Arabia's most innovative SMEs.
  • The authority led a delegation of Saudi start-ups, calling attention to their success and contributions to the national economy.
  • Events such as Web Summit 2023 enable us to do that, immersing some of our leading start-ups in an energized environment conducive to collaboration, innovation and growth."
  • Among the Saudi start-ups participating in Web Summit 2023 were: Zid, Lendo, Nuqtah, Syarah, Asasat Advanced Systems, Wosul, Kabi, Master Works, resal, WhiteHelmet, Mustadem, and Tachyon.

Monsha'at leads delegation of Saudi startups at Web Summit 2023

Retrieved on: 
Thursday, November 16, 2023
Kabi, SME, Web Summit, The Complete Master Works, Ecosystem, Small, Growth, MENA, Environment, Al-Nuqtah Mosque, Kingdom

Held from 13 to 16 November 2023 — in Lisbon, Portugal — the event provided Monsha'at the opportunity to spotlight Saudi Arabia's most innovative SMEs.

Key Points: 
  • Held from 13 to 16 November 2023 — in Lisbon, Portugal — the event provided Monsha'at the opportunity to spotlight Saudi Arabia's most innovative SMEs.
  • The authority led a delegation of Saudi start-ups, calling attention to their success and contributions to the national economy.
  • Events such as Web Summit 2023 enable us to do that, immersing some of our leading start-ups in an energized environment conducive to collaboration, innovation and growth."
  • Among the Saudi start-ups participating in Web Summit 2023 were: Zid, Lendo, Nuqtah, Syarah, Asasat Advanced Systems, Wosul, Kabi, Master Works, resal, WhiteHelmet, Mustadem, and Tachyon.

Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient

Retrieved on: 
Tuesday, October 3, 2023
Technology, Other Technology, Biotechnology, Other Health, Health, Pharmaceutical, Other Science, Science, Oncology, Fresenius (company), Automotive Executive of the Year Award, Multimedia, Kabi, Medication, Patient, Patient safety, Nursing, Vizient, Inc.

Fresenius Kabi has been named the 2023 Supplier Partner of the Year by Vizient, Inc ., the nation’s largest provider-driven health care performance improvement company.

Key Points: 
  • Fresenius Kabi has been named the 2023 Supplier Partner of the Year by Vizient, Inc ., the nation’s largest provider-driven health care performance improvement company.
  • View the full release here: https://www.businesswire.com/news/home/20231003375800/en/
    Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient.
  • In addition, Fresenius Kabi has been named Vizient’s Pharmaceutical Partner of the Year three times, and twice as the Vizient Strategic Programs Pharmaceutical Supplier of the Year in this time period.
  • “We are excited to recognize Fresenius Kabi as this year’s winner of the prestigious Supplier Partner of the Year Award.

Fresenius Kabi Selected for Second Consecutive Year to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange

Retrieved on: 
Monday, October 2, 2023
Medical Supplies, Health, Medical Devices, Health Technology, Other Health, Pharmaceutical, Vitamins, Supplements, Fresenius (company), Massachusetts Innovation & Technology Exchange, Pump, Vizient, Inc., Mohawk Innovative Technology, Exchange, BSN, Kabi, Zenith Contract Services, RN, MHA, Safety, Pharmaceutical industry, Nursing, Medical device

Fresenius Kabi has been selected to exhibit its Ivenix Infusion System at the Vizient Innovative Technology Exchange.

Key Points: 
  • Fresenius Kabi has been selected to exhibit its Ivenix Infusion System at the Vizient Innovative Technology Exchange.
  • The Ivenix Infusion System from Fresenius Kabi is designed to overcome deficiencies in legacy infusion pumps.
  • “We are excited to return to the Vizient Innovative Technology Exchange to demonstrate how the Ivenix Infusion System can help provide ease of use with infusion delivery.”
    “The Exchange is an exciting part of the Vizient Innovative Technology Program, which results in Innovative Technology contract awards for the qualified products.
  • Since 2003, Vizient has reviewed over 1,600 product submissions as part of its Innovative Technology Program.

Fresenius Kabi and AABB Announce Start of 18th Annual Blood Collectors Week September 3-9, 2023

Retrieved on: 
Sunday, September 3, 2023
General Health, Other Health, Health, Pharmaceutical, Medical Supplies, Partnership, CAE, Fresenius (company), Life, AABB, Transfusion medicine, Multimedia, Kabi, Patient, Blood, World Blood Donor Day, Social media, Safety, Medical device

Fresenius Kabi and AABB proudly announce the dates of the 18th annual Blood Collectors Week , which runs September 3-9, 2023.

Key Points: 
  • Fresenius Kabi and AABB proudly announce the dates of the 18th annual Blood Collectors Week , which runs September 3-9, 2023.
  • "We are delighted to partner with AABB once again to celebrate Blood Collectors Week and honor the unwavering dedication of blood collectors in the U.S.," said Dean Gregory, president, MedTech Global Commercial Operations at Fresenius Kabi.
  • “Our nation’s blood collectors are dedicated professionals who work tirelessly every day to ensure the safety and availability of the blood supply.
  • To learn more about blood donation, find a local blood collection site, or download resources for your Blood Collectors Week celebration, visit www.bloodcollectors.org .

Fresenius Kabi and Lupagen Enter into Strategic Development and Supply Agreement to Bring Cell and Gene Therapies to the Bedside

Retrieved on: 
Thursday, August 24, 2023
Hospitals, Genetics, Fitness & Nutrition, Stem Cells, Biotechnology, Other Health, Health, General Health, Oncology, Fresenius (company), Gene, Multimedia, Kabi, Collection, Patient, Blood, Cancer, Cell, Transfusion medicine, R, Rare, Autoimmunity, Vaccine, Medical device

Fresenius Kabi and Lupagen Inc. announced today the companies have entered into a development and supply agreement for technologies designed to bring the delivery of cell and gene therapies to the bedside.

Key Points: 
  • Fresenius Kabi and Lupagen Inc. announced today the companies have entered into a development and supply agreement for technologies designed to bring the delivery of cell and gene therapies to the bedside.
  • View the full release here: https://www.businesswire.com/news/home/20230824736387/en/
    Cell and gene therapies have shown great promise for a wide array of conditions including cancers and hematologic, autoimmune, and rare diseases.
  • Under the terms of the agreement, Fresenius Kabi will provide their expertise in apheresis collection and automated cell processing equipment to advance Lupagen’s Extracorporeal Cell and Gene Therapy Delivery System, which focuses on simplifying and reducing costs for cell and gene therapy through a bedside procedure.
  • “Lupagen’s mission is to make cell and gene therapy as common and widely accessible as standard blood transfusion or dialysis procedures.

Fresenius Kabi Launches Single-Needle Option for the Amicus® Extracorporeal Photopheresis Protocol

Retrieved on: 
Sunday, April 23, 2023
Pharmaceutical, Medical Supplies, Surgery, Oncology, Health, Diabetes, Medical Devices, Hospitals, CE, TPE, Fresenius (company), ECP, Cutaneous T-cell lymphoma, CTCL, Amicus, Medical Device Regulation Act, Kabi, Sale, Medical device regulation, MNC, Patient, Collection, Physician, Skin, Medical device, EU

Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.

Key Points: 
  • Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.
  • The Amicus Blue System with online ECP was launched in Europe in 2019 with double-needle venous access only.
  • “We are thrilled to enable the single-needle option for the Amicus Blue ECP system, which will allow physicians to treat patients with limited venous access.
  • This builds on our Amicus Blue vision to provide a versatile, multi-procedural instrument to support patients’ individual needs,” said Christian Hauer, President Fresenius Kabi MedTech.